Advertisement

Haemonetics Corporation HAE

Set alert

Price alert · HAE

All alert types
119.65 USD -0.14 -0.12%

At close

120.12 +0.47 +0.39%

Pre-market · Nov 2, 6:33 AM ET

Bid
119.61 × 100
Ask
119.93 × 100
118.40 Day range 120.47
49.24 52-week range 123.77
YTD
+49.28%
1 year
+139.25%
Open
120.50
Prev close
119.79
Mkt cap
5.44B
Vol
452.86K
Avg vol
725.65K
EPS
2.07
P/E
57.80
Div yield
0.00%
More statistics
Low
118.40
High
120.47
Forward P/E
20.72
Beta
0.61
Short ratio
4.81
Inst. own
112.49%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
109.75
200-d avg
78.42
1y target
124.50

5Y chart

Chart tools
Interval

Events in this range
  • Aug 7, 2025Earnings: 1.1; estimate 1.01; surprise 8.91%
  • Nov 6, 2025Earnings: 1.27; estimate 1.12; surprise 13.39%
  • Feb 5, 2026Earnings: 1.31; estimate 1.27; surprise 3.15%
  • May 7, 2026Earnings: 1.29; estimate 1.28; surprise 0.78%
  • Aug 6, 2026Earnings: 1.14; estimate 1.08; surprise 5.56%
  • Aug 21, 2026Rating: Baird · Outperform → Outperform
  • Sep 3, 2026Rating: Raymond James · Outperform → Outperform
  • Sep 17, 2026Rating: Citigroup · Neutral → Buy
  • Oct 8, 2026Rating: BTIG · Buy → Buy
  • Oct 9, 2026Rating: Mizuho · Outperform → Outperform
  • Oct 9, 2026Rating: Barrington Research · Outperform → Outperform
  • Nov 5, 2026Earnings: —; estimate 1.29; surprise —%
Signals (85)
NameDateAgo
RSI: OverboughtAug 3, 20263 months ago
SMA: BullishMay 25, 20265 months ago
SMA: BullishMay 18, 20265 months ago
MACD: Buy SignalMay 18, 20265 months ago
SMA: BearishApr 27, 20266 months ago
SMA: BullishApr 13, 20266 months ago
SMA: BearishFeb 2, 20269 months ago
MACD: Sell SignalJan 26, 20269 months ago
SMA: BearishJan 12, 20269 months ago
RSI: OverboughtDec 1, 202511 months ago
SMA: BullishNov 3, 202512 months ago
SMA: BullishNov 3, 202512 months ago
MACD: Buy SignalNov 3, 202512 months ago
SMA: BearishAug 4, 20251 year ago
SMA: BearishAug 4, 20251 year ago
MACD: Sell SignalAug 4, 20251 year ago
SMA: BullishJun 2, 20251 year ago
MACD: Buy SignalMay 5, 20251 year ago
SMA: BullishApr 28, 20251 year ago
MACD: Sell SignalJan 6, 20251 year ago
SMA: BearishDec 16, 20241 year ago
SMA: BearishDec 2, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BullishNov 4, 20241 year ago
MACD: Buy SignalNov 4, 20241 year ago
SMA: BearishOct 21, 20242 years ago
SMA: BullishOct 14, 20242 years ago
SMA: BearishOct 7, 20242 years ago
SMA: BullishSep 23, 20242 years ago
SMA: BearishAug 5, 20242 years ago
SMA: BearishAug 5, 20242 years ago
MACD: Sell SignalAug 5, 20242 years ago
SMA: BullishJul 8, 20242 years ago
MACD: Buy SignalJul 8, 20242 years ago
SMA: BullishJul 1, 20242 years ago
SMA: BearishJun 24, 20242 years ago
MACD: Sell SignalJun 17, 20242 years ago
SMA: BearishMay 27, 20242 years ago
SMA: BullishApr 22, 20242 years ago
SMA: BearishApr 15, 20242 years ago
SMA: BullishMar 25, 20242 years ago
MACD: Buy SignalMar 25, 20242 years ago
SMA: BullishMar 18, 20242 years ago
SMA: BearishMar 11, 20242 years ago
SMA: BullishMar 4, 20242 years ago
SMA: BearishDec 25, 20232 years ago
SMA: BearishDec 25, 20232 years ago
SMA: BullishDec 11, 20232 years ago
SMA: BullishDec 11, 20232 years ago
SMA: BearishNov 6, 20232 years ago
SMA: BullishOct 30, 20233 years ago
SMA: BearishOct 23, 20233 years ago
SMA: BearishOct 23, 20233 years ago
SMA: BullishOct 2, 20233 years ago
SMA: BearishSep 25, 20233 years ago
SMA: BullishSep 11, 20233 years ago
SMA: BearishSep 4, 20233 years ago
SMA: BullishAug 21, 20233 years ago
MACD: Sell SignalAug 21, 20233 years ago
SMA: BearishAug 14, 20233 years ago
SMA: BullishJul 17, 20233 years ago
MACD: Buy SignalJul 17, 20233 years ago
MACD: Sell SignalJun 19, 20233 years ago
SMA: BearishJun 12, 20233 years ago
SMA: BullishMay 29, 20233 years ago
SMA: BearishMay 22, 20233 years ago
MACD: Buy SignalMay 8, 20233 years ago
MACD: Sell SignalMay 1, 20233 years ago
MACD: Buy SignalApr 24, 20233 years ago
SMA: BullishMar 27, 20233 years ago
SMA: BullishMar 27, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
SMA: BearishFeb 6, 20233 years ago
MACD: Sell SignalFeb 6, 20233 years ago
MACD: Buy SignalJan 30, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BearishJan 2, 20233 years ago
SMA: BearishDec 5, 20223 years ago
MACD: Sell SignalDec 5, 20223 years ago
SMA: BullishOct 3, 20224 years ago
SMA: BearishSep 26, 20224 years ago
SMA: BullishMay 16, 20224 years ago
SMA: BearishApr 11, 20224 years ago
SMA: BullishFeb 7, 20224 years ago

Key statistics

Market cap
5.45B
Enterprise value
6.40B
Trailing P/E
57.83
Forward P/E
20.72
PEG ratio
1.90
Price / sales
4.03
Price / book
6.50
EPS (TTM)
2.07
Beta
0.61
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
7.12%
Revenue (TTM)
1.35B
Revenue growth
5.60%
Free cash flow
312.84M
Total cash
224.52M
Total debt
1.17B
Return on equity
11.20%
Shares outstanding
45.50M
Short % of float
8.82%
50-day average
109.75
200-day average
78.42

Analyst view

Consensus: buy

Buy
Price target (mean) 124.50 +4.1% upside
Target (low)
86.00
Target (mean)
124.50
Target (high)
142.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
  • Strong buy4
  • Buy5
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 1.29.

Earnings history

Financials — quick view

All financials
HAE Revenue — quarterly 339.38M
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
HAE Net income — quarterly 33.01M
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
HAE EPS — quarterly 0.73
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026

Earnings

HAE recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 27, 20261.29———
Aug 6, 2026Jun 27, 20261.081.14+0.06+5.56%
May 7, 2026Mar 28, 20261.281.29+0.01+0.78%
Feb 5, 2026Dec 27, 20251.271.31+0.04+3.15%
Nov 6, 2025Sep 27, 20251.121.27+0.15+13.39%
Aug 7, 2025Jun 28, 20251.011.10+0.09+8.91%

Upgrades / downgrades

HAE analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026Barrington ResearchmainOutperformOutperform
Oct 9, 2026MizuhomainOutperformOutperform
Oct 8, 2026BTIGmainBuyBuy
Sep 17, 2026CitigroupupNeutralBuy
Sep 3, 2026Raymond JamesmainOutperformOutperform
Aug 21, 2026BairdmainOutperformOutperform

About Haemonetics Corporation

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, it provides hospital products comprising TEG 6s system, smallest cartridge-based viscoelastic analyzer that provides a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, the company offers Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries;vascular closure products comprise VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen; and transfusion management solutions. It sells its products through direct sales force and independent distributors. The company was founded in 1971 and is headquartered in Boston, Massachusetts.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on HAE — it syncs with the Stock Master app.

Insider holders

HAE insider holders
InsiderRelationLatest transactionDateShares held
ABERNATHY ROBERT EDirectorStock Award(Grant)Jul 23, 202627,519
BASIL MICHELLE LGeneral CounselStock Award(Grant)May 14, 202668,829
DARECCA JAMESChief Financial OfficerStock Award(Grant)May 14, 202654,444
DOCKENDORFF CHARLES JDirectorStock Award(Grant)Jul 23, 202525,041
GALVIN ROYOfficerStock Award(Grant)May 14, 202639,882
KROLL MARK WDirectorStock Award(Grant)Jul 23, 202627,295

Institution ownership

HAE institution ownership
Holder% heldSharesValueReported
Blackrock Inc.12.99%5,909,258707.33MJun 29, 2026
Neuberger Berman Group, LLC9.19%4,179,443500.28MJun 29, 2026
Vanguard Portfolio Management LLC5.60%2,546,394304.80MJun 29, 2026
AQR Capital Management, LLC4.98%2,266,489271.30MJun 29, 2026
Vanguard Capital Management LLC4.53%2,059,578246.53MJun 29, 2026
Ariel Investments, LLC4.53%2,060,966246.70MJun 29, 2026

Fund ownership

HAE fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Mid-Cap ETF3.56%1,621,301194.07MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%1,441,654172.56MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.62%1,194,166142.94MSep 29, 2026
NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund2.59%1,179,168141.15MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.29%1,041,356124.65MJun 29, 2026
Touchstone Strategic TRT-Touchstone Strategic TRT-Touchstone Small Com1.35%614,82473.59MJun 29, 2026
Advertisement